Tag Archives: Tetrahydrocannabinol

New Research: CBC Cannabinoid Sparks Brain Cell Growth

This is just another in a long line of studies that invalidate the arguments that the mind control propagandists have used to put fear in people about drugs in general and Cannabis in particular.
They’re going down hard. (E)


IS HEMP A MIRACLE PLANT THAT CAN SAVE THE WORLD?

Click on the Truth Theory Logo for more articles, videos and other media on topics ranging from health to science, politics to conspiracies, as well as information on UFO’s, 911, historical mysteries and more. Great site! (E) 

`

by Jeffrey Green

Hemp is perhaps the answer to most problems in the world.  Ambitious, yes.  An exaggeration, no.

If grown extensively, its diverse uses can be of significant value to the environment, the economy, world hunger, personal health, and so much more.

For the environment, hemp can reduce deforestation, pesticide use, provide a sustainable biofuel, and replace GMO cotton among other benefits. It grows like a weed without the need for pesticides or heavy fertilizers.

Hemp does just about anything wood can do and it only takes 6 months to renew, not 20 years. It can be used to make paper, to build homes with, and as fuel for fire.

Hemp clothing is far more durable than cotton, which is an industry still operating a form of slavery from cultivation to production. GMO cotton has led to indentured servitude for Indian farmers where failed crops and debt result in shockingly high suicide rates. Hemp is simply a better material for clothing.

The oil in the hemp seed can be made into biodiesel just like any vegetable oil. Most arguments against biofuels are that their crops take up too much valuable farm land that should be used for food, and it takes more energy than it gives back when all things are considered (fertilizer, pesticides, planting and harvesting machinery, refining).

With hemp, biofuel is merely a bi-product of this crop, not it’s main use. The fiber of the plant is still an extremely valuable commodity. Whereas corn ethanol needs a lot of land with tons of intensive chemicals, and the process of turning corn into ethanol is then a net energy loss.

As today’s economy falters due to a variety of systematic problems, the world is in desperate need of a new industry. Worldwide hemp legalization and promotion would lead to a revolution in nearly all major industries. Entrepreneurs would have a field day with textiles, plastics, body care, construction, etc.

Industrial hemp’s female counterpart, marijuana, provides effective natural medicine for a number of ailments. Cannabis is one of mankind’s oldest recorded healing plants. As its prohibition lessens, modern man is only just beginning to discover the exciting medical uses of marijuana, which are provably vast already.

Cannabis can ease pain, depression, anxiety, sleep disorders, PTSD, arthritis, and has even been proven to have anti-cancerous properties. When eaten or vaporized, cannabis is entirely beneficial as a natural alternative because any unwanted tars are not inhaled. Furthermorejuicing raw cannabis has many benefits and zero psychoactive effects.

Hemp alone is powerful enough to be a game changer for the environment and for human society as a whole. It’s time to unleash the hemp seed.

Please watch the very entertaining video about how hemp can save the world and share this information with everyone you know.


More Evidence that Cannabis Cures or Mitigates Many Diseases-From IMVA

Multiple Sclerosis

Posted by Mark Sircus – Director on 21 November 2011 | Filed under Medicine

http://blog.imva.info/medicine/multiple-sclerosis

Marijuana-Magnesium-Iodine-Mercury Exposure

image

An estimated 350,000 people in the United States are living with multiple sclerosis (MS), a painful, debilitating, and sometimes fatal disorder of the central nervous system, and the United States government could care less and would doom this population to more suffering than can be imagined. A long list of ugly words comes to mind when one thinks of any person, organization or institution that would keep helpful and safe medicines away from MS sufferers.

MS is the most common debilitating neurological disease of young people, often appearing between the ages of 20 and 40, and affecting more women than men. Symptoms vary considerably from person to person; however, the one most frequently noted is spasticity, which causes pain, spasms, loss of function, and difficulties in nursing care.

MS exacerbations appear to be caused by abnormal immune activity that causes inflammation and the destruction of myelin, the protective covering of nerve fibers, in the brain or spinal cord. MS most frequently presents at onset as a relapsing and remitting disorder, where symptoms come and go. Current treatment of MS is primarily based on symptoms, focusing on such problems as spasticity, pain, fatigue, bladder problems and depression.

Anecdotal reports and a small controlled study have reported that cannabis improved spasticity and, to some extent, improved tremor in MS patients. Many studies of the pharmacology of cannabis have identified effects on motor systems of the central nervous system that have the potential of affecting tremor and spasticity. A recent carefully controlled study of the efficacy of THC in experimental allergic encephalomyelitis, the animal model of MS, demonstrated significant amelioration of these two MS symptoms. Moreover, cannabis has demonstrated effects on immune function that also have the potential ofreducing the autoimmune attack that is thought to be the underlying pathogenic process in MS.[1]

MS patients report that cannabis has a startling and profound effect on muscle spasms, tremors, balance, bladder control, speech and eyesight. Many wheelchair-bound patients report that they can walk unaided when they have smoked cannabis.

A House of Lords report states that the British Multiple Sclerosis Society (consisting of some 35,000 MS-suffering patients) estimates that as many as 4% of their population already use cannabis for the relief of their symptoms despite the considerable legal risks associated with prohibition. The chairman of the committee went on to state that, “We have seen enough evidence to convince us that a doctor might legitimately want to prescribe cannabis to relieve… the symptoms of multiple sclerosis and that the criminal law ought not to stand in the way.”

Numerous case studies, surveys and double-blind studies have reported improvement in patients treated with cannabinoids for symptoms including spasticity,[2],[3],[4] chronic pain, tremor, sexual dysfunction, bowel and bladder dysfunctions, vision dimness, dysfunctions of walking and balance (ataxia), and memory loss.[5],[6],[7]Cannabinoids have been shown in animal models to measurably lessen MS symptoms and may also halt the progression of the disease.[8]

A recent British survey of MS patients found that 43 percent of respondents used cannabis therapeutically. Among them, nearly three quarters said that cannabis mitigated their spasms, and more than half said it alleviated their pain. A survey published in August 2003 in the Canadian Journal of Neurological Sciences reported that 96 percent of Canadian MS patients believe that cannabis is therapeutically useful for treating the disease. Of those who admitted using cannabis medicinally, the majority found it to be beneficial, particularly in the treatment of chronic pain, spasticity, and depression.[9]

A U.K. study published recently in the journal Lancet looked at 630 multiple sclerosis patients after 15 weeks of orally delivered treatment. Fifty-seven percent of the patients taking a whole cannabis extract said their pain had eased compared with 50% who took capsules containing THC and 37% who were given placebo capsules.

Scientists have long been exploring the potential of cannabinoids to inhibit neurodegeneration. A 2003 study that the American MS Society calls “interesting and potentially exciting” demonstrated that cannabinoids were able to slow the disease process in mice by offering neuroprotection against EAE.[10] After analyzing the findings, authors at London’s Institute of Neurology concluded, “In addition to symptom management,cannabis may also slow down the neurodegenerative processes that ultimately lead to chronic disability in multiple sclerosis and probably other diseases.” [11]

Over 40 medicines are listed by the Multiple Sclerosis Society as commonly used by MS patients. Drugs commonly prescribed for muscle spasticity and tremor include Klonopin, Dantrium, Baclofen (Medtronic), Zanaflex and Valium. Klonopin (Clonazepam) and Valium (diazepam) are both benzodiazepines, central nervous system (CNS) depressants manufactured by Roche. Overdoses of these medications, especially when taken with alcohol, may lead to unconsciousness and death.

These drugs frequently cause people to become drowsy, dizzy, lightheaded, clumsy, or unsteady. Other common side effects include slurred speech, abdominal cramps or pain, blurred vision or other changes in vision, changes in sexual drive or performance, gastrointestinal changes, including constipation or diarrhea, dryness of mouth, fast or pounding heartbeat, muscle spasm, trouble with urination, and trembling. Studies in animals have shown that clonazepam and diazepam can cause birth defects or other problems, including death of the animal fetus. Overuse of clonazepam during pregnancy may cause the baby to become dependent on it and it may pass into breast milk and cause drowsiness, slow heartbeat, shortness of breath, or troubled breathing in nursing babies. By comparison, the side effects associated with cannabis are typically mild and are classified as “low risk.” Euphoric mood changes are among the most frequent side effects.

Some doctors are exceptionally dense when it comes to using medical marijuana. Dr. Jacqueline Friedman would rather inject botulinum toxin injections instead.[12] In 2009 the National Multiple Sclerosis Society released recommendations on marijuana as a treatment for MS, stating, “Although it is clear that cannabinoids have a potential for both management of MS symptoms such as pain and spasticity, as well as for neuroprotection, it cannot yet be recommended because … studies to date do not demonstrate a clear benefit compared to existing symptomatic therapies and… issues of side effects, systemic effects and long-term effects are not yet clear.”

Magnesium and MS

Although the cause remains officially unknown, multiple sclerosis is widely thought to begin as an autoimmuneinflammation with magnesium deficiency at the core. In studies it’s been shown that there was a significantly lower value of magnesium than that seen in control cases. The most marked reduction of magnesium content was observed in CNS white matter including demyelinated plaques of MS samples.[13]

Magnesium protects the cells from aluminum, mercury, lead, cadmium, beryllium and nickel. Evidence is mounting that low levels of magnesium contribute to the heavy metal deposition in the brain that precedes Parkinson’s, multiple sclerosis and Alzheimer’s. Research has shown that the symptoms of MS are very similar to mercury poisoning.[14] Mercury contamination is one major cause of inflammation in our bodies.

The rate of relapse in multiple sclerosis was found to be
decreased with dietary magnesium supplementation.[15]

Magnesium deficiency causes and underpins chronic inflammatory syndrome. Inflammation is the missing link to explain the role of magnesium in many pathological conditions. Dr. Mazur says, “Magnesium deficiency contributes to an exaggerated response to immune stress and oxidative stress is the consequence of the inflammatory response.” Magnesium deficiencies feed the fires of inflammation and pain and it is magnesium that modulates cellular events involved in inflammation. Increases in extracellular magnesium concentration cause a decrease in the inflammatory response while reduction in the extracellular magnesium results in cell activation.

Magnesium is central to immunocompetence and
plays a crucial role in natural and adaptive immunity.
[16]

MS sufferers have a wide variety of symptoms that often begin rather abruptly and proceed at a highly variable and unpredictable pace. Common early symptoms include numbness, pins and needles sensations, incoordination, weakness especially in the legs, painful loss of vision in one eye, double vision, dizziness, pain at various sites, urinary symptoms and impotence. Symptoms of MS that are also symptoms of magnesium deficiency include muscle spasms, weakness, twitching, muscle atrophy, an inability to control the bladder, nystagmus (rapid eye movements), hearing loss, and osteoporosis.

What is essential to remember about treating pain with
magnesium is it treats both the symptom and the cause of pain.

Researchers have found oral magnesium therapy effective on patients with multiple sclerosis. In one formally reported case a 35-year-old woman suffered with severe spastic paraplegia resulting from multiple sclerosis (MS). A significant improvement in the spasticity was found after only one week from the onset of the treatment on the modified Ashworth scale, an improvement in the range of motion and in the measures of angles at resting position in the lower limbs.[17]

Nystagmus is characterized by an involuntary movement of the eyes, often noted as a shaky or wiggly movement and has been directly tied to magnesium deficiencies. People with MS also have higher rates of epilepsy than controls. Epilepsy has also been linked to magnesium deficiencies. Without doubt magnesium supplementation accompanied by pH control via diet and the use of sodium bicarbonate will do wonders for not only multiple sclerosis patients but also Alzheimer’s and Parkinson’s disease sufferers.

Iodine

The relatively low prevalence of multiple sclerosis in Japan, despite its temperate latitude, has puzzled many researchers. We know though that their soils have some of the world’s highest known levels of iodine caused by the use of seaweed as a fertilizer. Deficiencies of this essential trace element appear to be associated with many diseases, or birth defects, including goiter, cretinism, multiple sclerosis, amyotrophic lateral sclerosis and cancer of the thyroid and nervous system. People with MS may also have low levels of selenium or of glutathione peroxidase, an enzyme produced from selenium. A theory explaining the pathogenesis of MS concerns an increased stickiness of cellular plasma membranes, hampering normal vascular function of the brain. In agreement with that theory researchers have found significantly lowered selenium values and lowered glutathione peroxidase activities.[18]

MS and Mercury Exposure

The central nervous system is extremely sensitive and reacts to a combination of factors that allopathic doctors don’t normally consider or address. Toxic exposures, nutritional deficiencies and emotional anguish converge most pointedly on the nervous system with often catastrophic results. Toxic substances such as mercury, which the body is chronically exposed to, accumulates in the brain, pituitary gland, CNS, liver, kidneys, etc. and can damage, inhibit, and cause imbalances at very low levels of exposure. Heavy metals can cause major neurological, immunological, and metabolic damage.

Each individual will be seen to have their own unique combination of neurological, endocrine, and enzymatic imbalances along with autoimmunities that result from the above factors. Symptoms will vary resulting in different diagnoses: multiple sclerosis (MS), amyotrophic lateral sclerosis (ALS), Alzheimer’s disease (AD), or Parkinson’s disease (PD), systemic lupus erythematosus (SLE), and even rheumatoid arthritis (RA) and chronic fatigue syndrome (CFS).

Dental amalgam is documented by medical studies and medical lab tests to be the largest source of both inorganic and methyl mercury in most people who have several mercury amalgam fillings. Very low levels of exposure have been found to seriously affect individuals who are immune sensitive to toxic metals, or have an inability to detoxify metals due to deficient sulfoxidation or metallothionein function or other inhibited enzymatic processes related to detoxification or excretion of metals.

Amalgam exposures are commonly above government health guidelines. This is due to continuous vaporization of mercury from amalgam in the mouth, along with galvanic currents from mixed metals in the mouth that deposit the mercury in the gums and oral cavity. Mercury is one of the most toxic substances in existence and is known to bioaccumulate in the body of people and animals that have chronic exposure.

A large epidemiological study of 35,000 Americans by the National Institutes of Health, the nation’s principal health statistics agency, found that there was a significant correlation between having a greater than average number of dental amalgam surfaces and having chronic conditions such as epilepsy, MS, or migraine headaches. MS clusters in areas with high metals emissions from facilities such as metal smelters have been documented.

Mercury has been found to accumulate preferentially in the brain, major organs, hormone glands, and primary motor function related areas involved in ALS—such as the brain stem, cerebellum, rhombencephalon, dorsal root ganglia, and anterior horn motor neurons, which enervate the skeletal muscles.

Exposure to mercury and magnesium deficiencies are at the root of inflammation. Chelation of mercury will relieve many of the problems caused by it and restoring magnesium levels will protect our cells from the inflammation that mercury causes. Magnesium is a necessary factor in chelation, for without it chelation will not be successful.[19] Heavy metals like cadmium, lead, and mercury compete with nutritional magnesium, keeping it from availability to protect our cells. The healthy cell wall favors intake of nutrients and elimination of waste products and this is one of the reasons magnesium is so important in detoxification and chelation.

MS Seen through a Vascular Surgeon’s Eyes

Dr. Paolo Zamboni, a former vascular surgeon and professor at the University of Ferrara in northern Italy, has come upon an entirely new idea about what causes MS and how to treat it. He found that scientists who had studied the brains of MS patients had noticed higher levels of iron in their brain, not accounted for by age. The iron deposits had a unique pattern, often forming in the core of the brain, clustered around the veins that normally drain blood from the head. No one had ever fully explained this phenomenon, considering the excess iron a toxic byproduct of the MS itself. Using Doppler ultrasound, Dr. Zamboni began examining the necks of MS patients and found that almost 100 percent of the patients had a narrowing, twisting or outright blockage of the veins that are supposed to flush blood from the brain. He then checked these veins in healthy people, and found none of these malformations. Nor did he find these blockages in those with other neurological conditions.

What was astounding was that not only was the blood not flowing out of the brain, it was “refluxing” or reversing and flowing back upwards. Zamboni dubbed the vein disorder he discovered CCSVI, or chronic cerebrospinal venous insufficiency, and began publishing his preliminary research in neurology journals. He soon found that the severity of the vein blockages corresponded to the severity of the patient’s symptoms. Patients with only one vein blocked usually had milder forms of the disease; those with two or more damaged veins had more severe illness.

If key veins of MS patients are blocked, perhaps we can open them and restore normal blood flow? Yes doctors use balloons to open up blocked arteries that feed blood from the heart but there are many natural treatments that can help, such as using niacin and different enzymes as well as removing the heavy-metal buildups with chelation.


[1] Cannabinoids are chemicals that are found naturally in Marijuana. Researchers believe that these naturally found cannabinoids could create immune suppression. Much like steroids, but with fewer side effects, cannabinoids can “switch off” a portion of the immune response and bring down inflammation and hyperactivity of immune cells, possibly preventing or slowing some of the damage caused to the myelin by immune cells. The cannabinoids do this by interacting with the receptors on specific immune cells.http://ms.about.com/b/2009/05/19/chemical-in-marijuana-to-slow-multiple-sclerosis.htm

[2] Meinck H et al (1989). Effects of cannabinoids on spasticity and ataxia in multiple sclerosis. Journal of Neurology, 226: 120-122. http://www.druglibrary.org/schaffer/hemp/medical/ms1.htm

[3] Musty RE, Consroe P. (2002) Spastic disorders. In: Grotenhermen F, Russo EB, editors. Cannabis and cannabinoids: Pharmacology, toxicology, and therapeutic potential. Binghamton, NY. Haworth Press. p. 195-204.

[4] Petro DJ (2002). Cannabis in multiple sclerosis: Women’s health concerns. Journal of Cannabis Therapeutics, 2(3-4):161-175

[5] Consroe P et al (1997). The Perceived Effects of Smoked Cannabis on Patients with Multiple Sclerosis. European Neurology, 38: 44-48.

[6] Petro DJ et al (1981). Treatment of Human Spasticity with Delta-9-Tetrahydrocannabinol. Journal of Clinical Pharmacology, 21: 413-416. http: //www.druglibrary.org/schaffer/hemp/medical/spast1.htm

[7] Ungerleider J et al (1988). Delta-9-THC in the treatment of Spasticity Associated with Multiple Sclerosis. Advances in Alcohol and Substance Abuse, 7: 39-50.

[8] Growing L et al (1998). Therapeutic use of cannabis: clarifying the debate. Drug and Alcohol Review, 17: 445-452

[9] Baker D et al (2000). Cannabinoids control spasticity and tremor in a multiple sclerosis model. Nature, 404: 84-87.

[10] Achiron A et al (2000). Dexanabinol (HU-211) effect on experimental autoimmune encephalomyelitis: implications for the treatment of acute relapses of multiple sclerosis. Journal of Neuroimmunology, 102: 26-31.

[11] Pryce G et al (2003). Cannabinoids inhibit neurodegeneration in models of multiple sclerosis. Brain, Jul 22

[12] Commentary by Dr. Jacqueline Friedman:
“Cognitive deficits are increasingly being appreciated as a significant symptom in MS, affecting daily lives and careers. Given the variable and subjective results of cannabis findings thus far, the clear cognitive negative effects, and given that there are alternative treatments for spasticity and pain, including muscle relaxants, botulinum toxin injections, anti-epileptics, and tricyclics, which can be carefully measured and dosed, I see no current place for medical marijuana in our armamentarium at this time.” Her peer review comment to a study showing the benefits of cannabis treatment in MS. http://www.clinicalcorrelations.org/?p=2688

[13] Magnesium concentration in brains from multiple sclerosis patientsACTA NEUROL. SCAND. (Denmark), 1990, 81/3      197-200)
[15] Multiple sclerosis: Decreased relapse rate through dietary supplementation with calcium, magnesium and vitamin D; MED. HYPOTHESES (UK), 1986, 21/2 (193-200)

[16] Mag Res. 1992:5:281-93

[17] P. Rossier , S. van Erven and D. T. Wade  Rivermead Rehabilitation Centre, Abingdon Road, Oxford England (DOI) 10.1046/j.1468-1331.2000.00142.x

[18] Biol Trace Elem Res. 1988 Jan-Apr;15:179-203. Selenium in chronic neurologic diseases. Multiple sclerosis and Batten’s disease. Clausen J, Jensen GE, Nielsen SA. Institute for Life Sciences and Chemistry, University of Roskilde, Denmark.

[19] Magnesium ions constitute the physiologically active magnesium in the body; they are not attached to other substances and are free to join in biochemical body processes.5 This is one basic reason magnesium helps to detoxify toxic chemicals and helps eliminate heavy metals from the body. Another reason would be the part it plays in glutathione production but undoubtedly, as Dr. Haley indicates, the Mg-ATP provides the crucial energy to remove each toxicant. A magnesium ion is an atom that is missing two electrons, which makes it search to attach to something that will replace its missing electrons so it is actively and directly involved in diminishing heavy metal toxicity. Magnesium appears to be a competitive inhibitor of lead and cadmium. An increased level of magnesium has been shown to eliminate lead and cadmium through the urine and has also been reported to reduce the toxic effects of aluminum.

Related posts:

  1. Cannabinoids in Cancer Treatment
  2. Transdermal and Oral Cannabis
  3. Diabetes, Cannabinoid Therapy & Magnesium

Thank you to Dr. Mr Sircus’ Blog and all the work he does in getting this information out. I would strongly recommend people purchase his books and other materials as he has done extensive research into health issues across the spectrum of human disease and ailments.

He is also an expert in keeping healthy for those who just desire to keep their bodies finely tuned. Here is is Blog where you can sign up for his newsletter.  http://blog.imva.info/ and here is his research link called IMVA  imva.info


Cannabis Heals-And The Government Knows It!

Jack Herer

Jack Herer

The Truth About Hemp

(regardless of what this lying government says) 

In 1974, Virginia Medical College in Richmond, Virginia did research on tumors of the lung, brain, liver and kidney using mice and rats. Incredible things were done. The cancer stopped growing and in most cases even reversed itself 100 percent. Some of the mice who were given cancer and treated with cannabis actually lived longer than some of the control mice who were not even given cancer! It was found that marijuana is the best thing to treat cancer of the lungs, brain, etc. After that they were stopped from doing any more research at all, by first Nixon and then Ford. No research with positive results could be done, only research with negative results. That’s the way it’s been since 1975 until now, even though a 1999 marijuana study turned out to be positive also.

Jack Herer, Ah-ha Publishing, Austin, Texas, June 2011, pp. 71

Thanks to my friend Henry Garcia who writes a regular heath newsletter called “Divine Life”. Let me know if you are interested and I will give you contact info.

E

`
`
`
`

~

~


Cannabis Saves Baby’s Life

Medical Marijuana Saves Baby’s Life

PHOTO: Mike Hyde and his son.
ABC News reported:
Doctors said two-year-old Cash Hyde would likely die after they found a stage 4 brain tumor surrounding his optic nerve just a year ago this week. And he nearly did. After being subjected to seven different chemotherapy drugs, the little boy from Missoula, Montana suffered septic shock, a stroke and pulmonary hemorrhaging.
Cash was so sick he went 40 days without eating. His organs were threatening to shut down. His father, Mike Hyde, intervened, slipping cannabis oil into his son’s feeding tube. Cash, now three, made a miraculous recovery at Primary Children’s Hospital in Salt Lake City, but his father’s bold action—taken behind the doctors’ backs—has raised serious questions about a parent’s role in medical treatment.
He was given the highest possible doses of chemotherapy for two months. He lost his appetite and threw up eight to 10 times a day. “When he started the chemo, he was so sick,” said Hyde. “For the first six weeks, he was blind. But his tumor was shrinking… It’s the nastiest thing to see someone you love go through this.”
By September, Cash had not been eating for 40 days. “He was suffering terribly, and the doctors said it was the best they could do for him,” said Hyde, who asked doctors to stop the chemotherapy drugs. Instead, Hyde boiled up marijuana he had purchased in Montana with olive oil and measured 3 mm doses that he poured into his son’s G-tube twice a day. “Not only was it helpful, it was a godsend. In two weeks he was weaned of all the nausea drugs, and he was eating again and sitting up in and laughing,” according to Hyde, who said doctors called his son’s recovery “a miracle.”
There is no surprise in the above clinical picture. Doctors, medical officials and the American federal government have got to be kidding themselves and everyone else with their negative and closed-minded attitudes toward medical marijuana. Though medical marijuana laws are being passed in state after state, oncologists prefer to remain stupid about how it can be used for cancer patients.
Tetrahydrocannabinol (THC), the main active
component of marijuana, induces human glioma
cell death through stimulation of autophagy.
[1],[2]
On the federal level the government and even the president prefer to remain cruel and hateful about marijuana—so much so that they would rather see the entire country destroyed by the war against drugs than show any consideration or empathy toward the plight of cancer sufferers and their need for safe, low-cost and effective cancer treatments. The violence in Mexico is an example of how such a war can destroy a country from within.
Cannabis (THC) can be found in
the prescription drug Marinol.
Combining the two most common cannabinoid compounds in cannabis boosts the effectiveness of treatments to inhibit the growth of brain cancer cells and increase the number of those cells that die off. Researchers at the California Pacific Medical Center Research Institute (CPMCRI) combined the non-psychoactive cannabis compound, cannabidiol (CBD), with Δ9-tetrahyrdocannabinol (Δ9-THC), the primary psychoactive active ingredient in cannabis. They found the combination boosts the inhibitory effects of Δ9-THC on glioblastoma, the most common and aggressive form of brain tumor and the cancer that claimed the life of Sen. Ted Kennedy last year.[3]
Is it really wise to treat children and adults with chemical poisons (chemotherapy) or radiation? Aren’t we already getting enough radiation exposure today thanks to the nuclear power industry (Fukushima)? Radiological departments need to dramatically reduce their use of radiation for diagnostic purposes and preferably eliminate its use for the treatment of cancer.
Today more than ever before we need a new paradigm for allopathic medicine! Since we cannot get rid of the field of contemporary medicine it needs to be reformed from the inside out and the only way to do that is to get into the underlying structure of its principles and practices and change them on a foundational level.
To be honest we know that this is as impossible as bringing Fukushima under control. It really is too much to expect doctors, especially pediatric oncologists, to understand that in an age of toxicity where patients are being heavily exposed to heavy metals, chemicals and radioactive particles, the last thing they need is exposure to more of the same via medical treatments and diagnostic procedures.
Dr. Linda Granowetter, a professor of pediatrics at New York University and chief of the Division of Pediatric Hematology and Oncology, told ABC News that Hyde’s intervention was “fascinating” but “somewhat bothersome. I think that the fact that he didn’t have the rapport and ability to be honest with the doctor is very troubling. Care is impeded when there is not complete trust.”
That this doctor actually believes what she is saying shows how impossible the situation is. How any doctor today could possibly believe that they merit such trust is beyond comprehension. Today doctors, especially pediatricians, are highly skilled in taking advantage of or abusing parents’ vulnerabilities and their fears about the medical treatment their children receive.
Thankfully the laws of natural selection are going to work their magic against such doctors and their treatments, for no one, including the government, is going to be able to afford them. Like big fat dangerous dinosaurs they will be crushed under the weight of the coming economic collapse.
Any doctor today who cannot grasp the reality that we are living in an age of toxicity full of poisonous chemicals, heavy metals and radioactive particles is a charlatan and a danger to society. It is a very bad situation that has just recently, and in the space of a very short period of time, gotten much worse.
Oncologists would rather have little kids like Cash
die then have them take THC for their cancer.
Contemporary medicine is committing a form of mass suicide by not responding to the need to reduce people’s exposure to chemicals, radiation and heavy metals rather than adding to that exposure. Hopefully, a new medicine and a new field of dentistry will embrace as its most fundamental principle a reduction of exposure to poisons as a holy medical principle.
Dr. Granowetter was quoted as saying, “We know from research that 30 to 60 percent of parents with children are giving them alternative meds like vitamins, shark tooth and herbs from Chinatown. That’s why we spend a lot of time asking parents what else they are giving kids and trying to be non-judgmental and work with them and guide them.” She said most pediatric oncologists are “open-minded” about alternative treatments.
I wonder who Granowetter thinks she is kidding with the mention of shark teeth and herbs from Chinatown. Did she mean shark cartilage? I have never heard of an open-minded pediatrician, have you? If you want to test them try speaking about your reasons to not vaccinate or try refusing chemo or radiation therapy once it has been indicated.
A boy with 11 tumors, who was sent home to die, survives
after his grandparents’ alternative therapy treatments.
I get sick every time I hear a story of how oncologists have called in the police to force parents to treat their children with chemo and radiation therapy. It really is too bad that there is no one we can call to get rid of such doctors and institutions that support them with fascist fervor. Instead of Ghostbusters we need a group to bust up the field of pediatric oncology. The arrogance of pediatricians will continue to reverberate through our race consciousness as children are killed and families are ruined because of their brainless beliefs and practices.
Special Note: Please note in the story on ABC News that Mike Hyde made his own hemp oil. Rick Simpson, who continues to be a rock of integrity about the use of hemp oil for the cure of cancer, warns people to make it themselves because the quality of purchased oil is highly questionable. Simpson said:
“That’s the reason I tell the public it’s best to produce your own oil at this time, until we have some standards in place. If you produce the oil yourself, at least then you know you have the real thing and to a dying patient, the proper oil can mean the difference between life and death.
“The public must realize that all hemp is not created equal, the medicinal qualities from strain to strain can vary a great deal so the proper strains must be used. Also low-grade strains and clippings may produce a decent treatment for some skin conditions. But if you are trying to treat someone with a serious condition like cancer, low-grade oils just don’t cut it, only the best will do.
“These are trying times for us all, but soon things will settle down and the public will have their medicine. It’s just a matter of time now, for there is no way for the system to stop the truth from spreading. Properly produced hemp oil is the greatest medicine on this earth, and soon hemp will again take its rightful place in mainstream medicinal use.”
Dr. Mark Allan Sircus, Ac., OMD, DM (P)
Director International Medical Veritas Association
Doctor of Oriental and Pastoral Medicine
http://publications.imva.info
http://blog.imva.info

Recent Research on Medical Marijuana

Emerging Clinical Applications For Cannabis & Cannabinoids
A Review of the Recent Scientific Literature, 2000 — 2011

 

Despite the ongoing political debate regarding the legality of medicinal marijuana, clinical investigations of the therapeutic use of cannabinoids are now more prevalent than at any time in history.

For example, in February 2010 investigators at the University of California Center for Medicinal Cannabis Research publicly announced thefindings of a series of randomized, placebo-controlled clinical trials on the medical utility of inhaled cannabis. The studies, which utilized the so-called ‘gold standard’ FDA clinical trail design, concluded that marijuana ought to be a “first line treatment” for patients with neuropathy and other serious illnesses.

Among the studies conducted by the Center, four assessed smoked marijuana’s ability to alleviate neuropathic pain, a notoriously difficult to treat type of nerve-pain associated with cancer, diabetes, HIV/AIDS, spinal cord injury, and many other debilitating conditions. Each of the trials found that cannabis consistently reduced patients’ pain levels to a degree that was as good or better than currently available medications.

Another study conducted by the Center’s investigators assessed the use of marijuana as a treatment for patients suffering frommultiple sclerosis. That study determined that “smoked cannabis was superior to placebo in reducing spasticity and pain in patients with MS, and provided some benefit beyond currently prescribed treatments.”

Around the globe similarly controlled trials are also taking place. A 2010 review by researchers in Germany reports that since 2005 there have been 37 controlled studies assessing the safety and efficacy of marijuana and its naturally occurring compounds, involved a total of 2,563 subjects. By contrast, most FDA-approved drugs go through far fewer trials involving far fewer subjects.

While much of the renewed interest in cannabinoid therapeutics is a result of the discovery of the endocannabinoid regulatory system (which we describe in detail later in this booklet), some of this increased attention is also due to the growing body of testimonials from medicinal cannabis patients and their physicians. Nevertheless, despite this influx of anecdotal reports, much of the modern investigation of medicinal cannabis remains limited to preclinical (animal) studies of individual cannabinoids (e.g. THC or cannabidiol) and/or synthetic cannabinoid agonists (e.g., dronabinol or WIN 55,212-2) rather than clinical trial investigations involving whole plant material. Predictably, because of the US government’s strong public policy stance against any use of cannabis, the bulk of this modern cannabinoid research is taking place outside the United States.

As clinical research into the therapeutic value of cannabinoids has proliferated – there are now an estimated 20,000 published papers in the scientific literature analyzing marijuana and its constituents — so too has investigators’ understanding of cannabis’ remarkable capability to combat disease. Whereas researchers in the 1970s, 80s, and 90s primarily assessed cannabis’ ability to temporarily alleviate various disease symptoms — such as the nausea associated with cancer chemotherapy — scientists today are exploring the potential role of cannabinoids tomodify disease.

Of particular interest, scientists are investigating cannabinoids’ capacity to moderate autoimmune disorders such as multiple sclerosis,rheumatoid arthritis, and inflammatory bowel disease, as well as their role in the treatment of neurological disorders such as Alzheimer’s disease and amyotrophic lateral sclerosis (a.k.a. Lou Gehrig’s disease.) In fact, in 2009 the American Medical Association (AMA) resolved for the first time in the organization’s history “that marijuana’s status as a federal Schedule I controlled substance be reviewed with the goal of facilitating the conduct of clinical research and development of cannabinoid-based medicines.”

Investigators are also studying the anti-cancer activities of cannabis, as a growing body of preclinical and clinical data concludes that cannabinoids can reduce the spread of specific cancer cells via apoptosis (programmed cell death) and by the inhibition of angiogenesis (the formation of new blood vessels). Arguably, these latter trends represent far broader and more significant applications for cannabinoid therapeutics than researchers could have imagined some thirty or even twenty years ago.

THE SAFETY PROFILE OF MEDICAL CANNABIS

Cannabinoids have a remarkable safety record, particularly when compared to other therapeutically active substances. Most significantly, the consumption of marijuana – regardless of quantity or potency — cannot induce a fatal overdose. According to a 1995 review prepared for the World Health Organization, “There are no recorded cases of overdose fatalities attributed to cannabis, and the estimated lethal dose for humans extrapolated from animal studies is so high that it cannot be achieved by … users.”

In 2008, investigators at McGill University Health Centre and McGill University in Montreal and the University of British Columbia in Vancouverreviewed 23 clinical investigations of medicinal cannabinoid drugs (typically oral THC or liquid cannabis extracts) and eight observational studies conducted between 1966 and 2007. Investigators “did not find a higher incidence rate of serious adverse events associated with medical cannabinoid use” compared to non-using controls over these four decades.

That said, cannabis should not necessarily be viewed as a ‘harmless’ substance. Its active constituents may produce a variety of physiological and euphoric effects. As a result, there may be some populations that are susceptible to increased risks from the use of cannabis, such asadolescentspregnant or nursing mothers, and patients who have a family history of mental illness. Patients with Hepatitis C, decreased lung function (such as chronic obstructive pulmonary disease), or who have a history of heart disease or stroke may also be at a greater risk of experiencing adverse side effects from marijuana. As with any medication, patients should consult thoroughly with their physician before deciding whether the medicinal use of cannabis is safe and appropriate.

HOW TO USE THIS REPORT

As states continue to approve legislation enabling the physician-supervised use of medicinal marijuana, more patients with varying disease types are exploring the use of therapeutic cannabis. Many of these patients and their physicians are now discussing this issue for the first time, and are seeking guidance on whether the therapeutic use of cannabis may or may not be advisable. This report seeks to provide this guidance by summarizing the most recently published scientific research (2000-2010) on the therapeutic use of cannabis and cannabinoids for 19 clinical indications:

Alzheimer’s disease
Amyotrophic lateral sclerosis
Chronic Pain
Diabetes mellitus
Dystonia
Fibromyalgia
Gastrointestinal disorders
Gliomas
Hepatitis C
Human Immunodeficiency Virus
Hypertension
Incontinence
Methicillin-resistant Staphyloccus aureus (MRSA)
Multiple sclerosis
Osteoporosis
Pruritus
Rheumatoid arthritis
Sleep apnea
Tourette’s syndrome

In some of these cases, modern science is now affirming longtime anecdotal reports of medicinal cannabis users (e.g., the use of cannabis to alleviate GI disorders). In other cases, this research is highlighting entirely new potential clinical utilities for cannabinoids (e.g., the use of cannabinoids to modify the progression of diabetes.)

The conditions profiled in this report were chosen because patients frequently inquire about the therapeutic use of cannabis to treat these disorders. In addition, many of the indications included in this report may be moderated by cannabis therapy. In several cases, preclinical data and clinical data indicate that cannabinoids may halt the progression of these diseases in a more efficacious manner than available pharmaceuticals.

For patients and their physicians, let this report serve as a primer for those who are considering using or recommending medicinal cannabis. For others, let this report serve as an introduction to the broad range of emerging clinical applications for cannabis and its various compounds.

Paul Armentano
Deputy Director
NORML | NORML Foundation
Washington, DC
January 7, 2011

* The author would like to acknowledge Drs. Dale Gieringer, Dustin Sulak, Gregory Carter, Steven Karch, and Mitch Earleywine, as well as Bernard Ellis, MPH, former NORML interns John Lucy, Christopher Rasmussen, and Rita Bowles, for providing research assistance for this report. The NORML Foundation would also like to acknowledge Dale Gieringer, Paul Kuhn, and Richard Wolfe for their financial contributions toward the publication of this report.

** Important and timely publications such as this are only made possible when concerned citizens become involved with NORML. For more information on joining NORML or making a donation, please visit: http://www.norml.org/join. Tax-deductible donations in support of NORML’s public education campaigns should be made payable to the NORML Foundation.


Marijuana Two Minute Truths

Gateway Myth

The Addiction Question

Did you hear that? Marijuana is about as addictive as COFFEE. Scary!

 

Marijuana and the Brain

Doesn’t Cause Lung Cancer

Marijuana “Overdose”

Thanks to the Marijuana Policy Project

 

 


This Needs To Be Talked About

Cannabis for ADD-One More Reason to Legalize

This physician discusses how society has lied to adolescents about the “dangers” of Cannabis use and how the kids’ experiences differ from the “mantra”. (E)


Cannabis destroys cancer cells

3D rendering of the THC molecule.

Image via Wikipedia

Laboratory News Online

Scientists working in the UK have revealed that cannabis has the potential to destroy leukemia cells

Scientists working in the UK have revealed that cannabis has the potential to destroy leukemia cells.

The team – based at Queen Mary’s School of Medicine and Dentistry in London – have followed up on their previous findings that the main active ingredient in cannabis, tetrahydrocannabinol (THC) has the potential to be used effectively against some forms of cancer.

Use of cannabis as a therapeutic agent continues to be controversial due to its psychoactive side effects and consequent legal status, however, leader of the team, Dr Wai Man Liu, explains: “It is important to stress that these cannabis-like substances are far removed from the cannabis that is smoked. These novel compounds have been specifically designed to be free of the psychoactive features, whilst maintaining anti-cancer action.”

THC has previously been shown to attack cancer cells by interfering with important growth-processing pathways, however its mechanism of doing so has remained a mystery. Now, Dr Liu and his colleagues, using microarray technology – allowing them to simultaneously detect changes in more than 18,000 genes in cells treated with THC – have begun to uncover the existence of processes through which THC can kill cancer cells and potentially promote survival.

The researchers hope that the findings will provide a crucial step towards the development of new therapies for many types of cancer. Dr Liu said: “Ultimately, understanding the fundamental mechanisms of these compounds will provide us with insights into developing new drugs that can be used to effectively treat cancers.”


%d bloggers like this: